Experts discuss how to increase public opinion of clinical trials

The discussion between professionals of how to rebuild public trust regarding clinical trials may stem from the worldwide concern in the biomedical research community about the low capture rate of trials reported as reported on redOrbit.com.  One theory to help raise...

GSK takes leap into transparency

FierceBiotechIT writer Ryan McBride reports that GlaxoSmithKline (GSK) launched a website that will allow authorized researchers the ability to use clinical study data on certain drugs from the London based pharma company.  This launches GSK to the forefront of...

Support the “OK to Ask” campaign

Many doctors already discuss clinical research with patients, but in a recent study, only 21% of patients felt comfortable asking about research to their doctors.  The National Health Service, (NHS) is looking for patients and professionals to either ask or talk about...

Pearl Pathways’ own to speak at research conference

The St. Vincent Research and Regulatory Affairs will be hosting the 9th Annual St. Vincent Health Research Symposium on June 12th. Pearl Pathways’ own Ellen Looney, regulatory clinical & quality associate, will be featured, her topic, Good Clinical Practices...

Setback for EMA’s vision of transparency

Raps.org journalist, Alexander Gaffney reported that an EU court has surprisingly issued an interim order that the European Medicines Agency (EMA) should stop publishing any more information or documents until a final order has been passed regarding public...